Anuh Pharma Limited
In PositoAI's records, Anuh Pharma Limited has had 6 dividends since 2021 (₹10.75 per share in total); 2 bonus issues since 2016. Latest dividend: ₹1.5 per share, ex-date 5 Aug 2026.
Records start: dividends 2021, bonus and rights issues 2016, splits and buybacks 2022, mergers and demergers 2025. Earlier actions are not shown.
Anuh Pharma Limited Dividend History#
| Ex-date | Dividend |
|---|---|
| 2026 | ₹1.5 per share |
| 5 Aug 2026 | ₹1.5 per share |
| 2025 | ₹1.5 per share |
| 14 Aug 2025 | ₹1.5 per share |
| 2024 | ₹2.5 per share |
| 16 Aug 2024 | ₹2.5 per share |
| 2023 | ₹2 per share |
| 11 Aug 2023 | ₹2 per share |
| 2022 | ₹1.75 per share |
| 3 Aug 2022 | ₹1.75 per share |
| 2021 | ₹1.5 per share |
| 17 Aug 2021 | ₹1.5 per share |
Amounts are per share as declared, not adjusted for later bonus issues or splits.
Anuh Pharma Limited Bonus History#
| Ex-date | Details |
|---|---|
| 15 Jul 2025 | 1:1 (1 new share for every 1 held) |
| 18 Sep 2020 | 1:1 (1 new share for every 1 held) |
Questions
Does Anuh Pharma Limited pay dividends?
Yes. In PositoAI's records (from 2021), Anuh Pharma Limited has paid 6 dividends, the latest ₹1.5 per share with ex-date 5 August 2026.
How much dividend did Anuh Pharma Limited pay in 2025?
₹1.5 per share in 2025, in 1 payment.
Has Anuh Pharma Limited issued bonus shares?
Yes, 2 times in PositoAI's records (from 2016); the latest was 1:1 (1 new share for every 1 held) with ex-date 15 July 2025.
What is an ex-date and a record date?
To receive a dividend, bonus or other benefit, you must own the shares before the ex-date. The record date is the day the company checks its list of shareholders.
Records: dividends from 2021, bonus issues and rights issues from 2016, splits and buybacks from 2022, mergers and demergers from 2025; new actions are added every day. Amounts are per share in rupees. To receive a dividend or bonus, shares must be held before the ex-date. Please confirm dates with the company's own announcement. PositoAI is for research and education only and is not investment advice.